Advertisement
UK markets close in 2 hours 27 minutes
  • FTSE 100

    8,034.74
    +10.87 (+0.14%)
     
  • FTSE 250

    19,698.61
    +99.22 (+0.51%)
     
  • AIM

    753.23
    +4.05 (+0.54%)
     
  • GBP/EUR

    1.1612
    +0.0023 (+0.20%)
     
  • GBP/USD

    1.2388
    +0.0037 (+0.30%)
     
  • Bitcoin GBP

    53,406.32
    +40.68 (+0.08%)
     
  • CMC Crypto 200

    1,417.83
    +3.07 (+0.22%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    80.94
    -0.96 (-1.17%)
     
  • GOLD FUTURES

    2,323.90
    -22.50 (-0.96%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,050.38
    +189.58 (+1.06%)
     
  • CAC 40

    8,077.48
    +37.12 (+0.46%)
     

Shire selling four tranche US dollar bond for Baxalta buy :lead

By Mike Gambale

NEW YORK, Sept 19 (IFR) - Here is the pricing progression on

the new bond offering from drugmaker Shire (Hamburg: 3979575.HM - news) (Baa3/BBB-) to help

finance its acquisition of Baxalta (Berlin: 9BX.BE - news) , one of the banks leading the

deal told IFR.

The deal is expected to price later on Monday.

SIZE MATURITY IPTs (T+)

TBD 3yr FXD 120-125bp

TBD 5yr FXD 140-145bp

TBD 7yr FXD 160-165bp

TBD 10yr FXD 175-180bp

Active bookrunners: Bank of America Merrill Lynch, Barclays (LSE: BARC.L - news) ,

Morgan Stanley (Xetra: 885836 - news)

(Reporting by Mike Gambale; Editing by Natalie Harrison and

Marc Carnegie)